Overcoming the barriers to HPV vaccination in high-risk populations in the US

Levi S. Downs, Isabel Scarinci, Mark H. Einstein, Yvonne Collins, Lisa Flowers

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Objectives: To review populations of women in the United States at high risk for cervical cancer, assess known reasons for existing outcome disparities, and discuss potential strategies to reduce barriers to HPV vaccination and current strategies for cervical cancer prevention. Methods: An expert forum conducted September 12-13, 2008, by the Society of Gynecologic Oncologists including 56 experts in cervical cancer and titled "Future strategies of cervical cancer prevention: what do we need to do now to prepare?". Results: Although epidemiological data is useful and necessary to identify populations at high risk for cervical cancer, an understanding of the knowledge and attitudes regarding HPV and cervical cancer prevention of racial/ethnic groups and sub-groups within racial/ethnic categories is critical for the implementation of effective targeted and effective educational efforts. Inequities in cervical cancer screening, diagnosis and treatment and HPV vaccination may arise from a number of barriers including access to healthcare, cultural beliefs, and limited awareness of options. Conclusions: Initiatives to promote uptake of prophylactic HPV vaccination that target high-risk women need to be implemented before existing disparities widen. Although acceptability of HPV vaccination is promising, uptake is still low among low-income populations and specific racial/ethnic minorities. To address limited vaccine uptake it may be beneficial to establish national/state guidelines as well as culturally relevant interventions at the individual and community levels. The successful implementation of multiple integrated initiatives on HPV awareness, knowledge, and vaccination will diminish existing disparities in cervical cancer incidence and mortality.

Original languageEnglish (US)
Pages (from-to)486-490
Number of pages5
JournalGynecologic Oncology
Volume117
Issue number3
DOIs
StatePublished - Jun 2010

Fingerprint

Uterine Cervical Neoplasms
Vaccination
Population
Immunization Programs
Poverty
Early Detection of Cancer
Ethnic Groups
Vaccines
Guidelines
Delivery of Health Care
Mortality
Incidence

Keywords

  • Cancer prevention
  • Cervical cancer
  • Health disparities
  • HPV vaccine

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Downs, L. S., Scarinci, I., Einstein, M. H., Collins, Y., & Flowers, L. (2010). Overcoming the barriers to HPV vaccination in high-risk populations in the US. Gynecologic Oncology, 117(3), 486-490. https://doi.org/10.1016/j.ygyno.2010.02.011

Overcoming the barriers to HPV vaccination in high-risk populations in the US. / Downs, Levi S.; Scarinci, Isabel; Einstein, Mark H.; Collins, Yvonne; Flowers, Lisa.

In: Gynecologic Oncology, Vol. 117, No. 3, 06.2010, p. 486-490.

Research output: Contribution to journalArticle

Downs, LS, Scarinci, I, Einstein, MH, Collins, Y & Flowers, L 2010, 'Overcoming the barriers to HPV vaccination in high-risk populations in the US', Gynecologic Oncology, vol. 117, no. 3, pp. 486-490. https://doi.org/10.1016/j.ygyno.2010.02.011
Downs, Levi S. ; Scarinci, Isabel ; Einstein, Mark H. ; Collins, Yvonne ; Flowers, Lisa. / Overcoming the barriers to HPV vaccination in high-risk populations in the US. In: Gynecologic Oncology. 2010 ; Vol. 117, No. 3. pp. 486-490.
@article{bf6959f42ae048128122f3079de9910c,
title = "Overcoming the barriers to HPV vaccination in high-risk populations in the US",
abstract = "Objectives: To review populations of women in the United States at high risk for cervical cancer, assess known reasons for existing outcome disparities, and discuss potential strategies to reduce barriers to HPV vaccination and current strategies for cervical cancer prevention. Methods: An expert forum conducted September 12-13, 2008, by the Society of Gynecologic Oncologists including 56 experts in cervical cancer and titled {"}Future strategies of cervical cancer prevention: what do we need to do now to prepare?{"}. Results: Although epidemiological data is useful and necessary to identify populations at high risk for cervical cancer, an understanding of the knowledge and attitudes regarding HPV and cervical cancer prevention of racial/ethnic groups and sub-groups within racial/ethnic categories is critical for the implementation of effective targeted and effective educational efforts. Inequities in cervical cancer screening, diagnosis and treatment and HPV vaccination may arise from a number of barriers including access to healthcare, cultural beliefs, and limited awareness of options. Conclusions: Initiatives to promote uptake of prophylactic HPV vaccination that target high-risk women need to be implemented before existing disparities widen. Although acceptability of HPV vaccination is promising, uptake is still low among low-income populations and specific racial/ethnic minorities. To address limited vaccine uptake it may be beneficial to establish national/state guidelines as well as culturally relevant interventions at the individual and community levels. The successful implementation of multiple integrated initiatives on HPV awareness, knowledge, and vaccination will diminish existing disparities in cervical cancer incidence and mortality.",
keywords = "Cancer prevention, Cervical cancer, Health disparities, HPV vaccine",
author = "Downs, {Levi S.} and Isabel Scarinci and Einstein, {Mark H.} and Yvonne Collins and Lisa Flowers",
year = "2010",
month = "6",
doi = "10.1016/j.ygyno.2010.02.011",
language = "English (US)",
volume = "117",
pages = "486--490",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Overcoming the barriers to HPV vaccination in high-risk populations in the US

AU - Downs, Levi S.

AU - Scarinci, Isabel

AU - Einstein, Mark H.

AU - Collins, Yvonne

AU - Flowers, Lisa

PY - 2010/6

Y1 - 2010/6

N2 - Objectives: To review populations of women in the United States at high risk for cervical cancer, assess known reasons for existing outcome disparities, and discuss potential strategies to reduce barriers to HPV vaccination and current strategies for cervical cancer prevention. Methods: An expert forum conducted September 12-13, 2008, by the Society of Gynecologic Oncologists including 56 experts in cervical cancer and titled "Future strategies of cervical cancer prevention: what do we need to do now to prepare?". Results: Although epidemiological data is useful and necessary to identify populations at high risk for cervical cancer, an understanding of the knowledge and attitudes regarding HPV and cervical cancer prevention of racial/ethnic groups and sub-groups within racial/ethnic categories is critical for the implementation of effective targeted and effective educational efforts. Inequities in cervical cancer screening, diagnosis and treatment and HPV vaccination may arise from a number of barriers including access to healthcare, cultural beliefs, and limited awareness of options. Conclusions: Initiatives to promote uptake of prophylactic HPV vaccination that target high-risk women need to be implemented before existing disparities widen. Although acceptability of HPV vaccination is promising, uptake is still low among low-income populations and specific racial/ethnic minorities. To address limited vaccine uptake it may be beneficial to establish national/state guidelines as well as culturally relevant interventions at the individual and community levels. The successful implementation of multiple integrated initiatives on HPV awareness, knowledge, and vaccination will diminish existing disparities in cervical cancer incidence and mortality.

AB - Objectives: To review populations of women in the United States at high risk for cervical cancer, assess known reasons for existing outcome disparities, and discuss potential strategies to reduce barriers to HPV vaccination and current strategies for cervical cancer prevention. Methods: An expert forum conducted September 12-13, 2008, by the Society of Gynecologic Oncologists including 56 experts in cervical cancer and titled "Future strategies of cervical cancer prevention: what do we need to do now to prepare?". Results: Although epidemiological data is useful and necessary to identify populations at high risk for cervical cancer, an understanding of the knowledge and attitudes regarding HPV and cervical cancer prevention of racial/ethnic groups and sub-groups within racial/ethnic categories is critical for the implementation of effective targeted and effective educational efforts. Inequities in cervical cancer screening, diagnosis and treatment and HPV vaccination may arise from a number of barriers including access to healthcare, cultural beliefs, and limited awareness of options. Conclusions: Initiatives to promote uptake of prophylactic HPV vaccination that target high-risk women need to be implemented before existing disparities widen. Although acceptability of HPV vaccination is promising, uptake is still low among low-income populations and specific racial/ethnic minorities. To address limited vaccine uptake it may be beneficial to establish national/state guidelines as well as culturally relevant interventions at the individual and community levels. The successful implementation of multiple integrated initiatives on HPV awareness, knowledge, and vaccination will diminish existing disparities in cervical cancer incidence and mortality.

KW - Cancer prevention

KW - Cervical cancer

KW - Health disparities

KW - HPV vaccine

UR - http://www.scopus.com/inward/record.url?scp=77951891800&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951891800&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2010.02.011

DO - 10.1016/j.ygyno.2010.02.011

M3 - Article

C2 - 20303156

AN - SCOPUS:77951891800

VL - 117

SP - 486

EP - 490

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -